Physician profile
Amit Patel
NPI 1144414244
$1,198.93
in general payments reported to CMS, 2019-2025
16 companies · $87.31 in 2025
The $87.31 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $162 · 2022: $136 · 2023: $38.42 · 2024: $125 · 2025: $87.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $246.86 | 2019-2025 | Fasenra |
| Vifor Pharma, INC. | $238.72 | 2019 | |
| Mallinckrodt Enterprises LLC | $132.26 | 2019 | |
| Baxter Healthcare | $120.15 | 2022 | |
| Mallinckrodt Hospital Products INC. | $110.25 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.48 | 2024 | Jardiance |
| Pfizer INC. | $58.63 | 2020-2024 | |
| Opko Pharmaceuticals, LLC | $35.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.76 | 2025 | |
| Angiodynamics, INC. | $25.52 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $18.35 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.97 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $17.45 | 2023 | Eliquis |
| Astellas Pharma US INC | $15.79 | 2022 | |
| Edwards Lifesciences Corporation | $13.86 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.